The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Expression of a multidrug-resistance gene in human tumors and tissues.
Open accessAbstract
The identification and cloning of a segment of a human multidrug resistance gene (mdr1) was reported recently. To examine the molecular basis of one type of multidrug resistance, we have prepared RNA from human tumors and normal tissues and measured their content of mdr1 RNA. We find that the mdr1 gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at intermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues. The mdr1 gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon. In addition, increased expression was detected in a few tumors at the time of relapse following initial chemotherapy. Although controlled clinical studies will be required, our results suggest that measurement of mdr1 RNA may prove to be a valuable tool in the design of chemotherapy protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Self-citationTsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Biedler, J. L., & Riehm, H. (1970) · PubMed · Cited by 747
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
Self-citationHuman Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene Amplification
Shen, D.-W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., & Gottesman, M. M. (1986) · Science · doi:10.1126/science.3457471 · Cited by 603
Self-citationIsolation and genetic characterization of human KB cell lines resistant to multiple drugs
Akiyama, S.-I., Fojo, A., Hanover, J. A., Pastan, I., & Gottesman, M. M. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534700 · Cited by 529
Self-citationAltered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.
Beck, W. T., Mueller, T. J., & Tanzer, L. R. (1979) · PubMed · Cited by 501
Cited by
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Self-citationThiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Self-citationCordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
Self-citationDrug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,085
Ueda, K., Cardarelli, C., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3004 · Cited by 1,063
Self-citationKim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
Staatz, C. E., & Tett, S. E. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443100-00001 · Cited by 913
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
The Role of ABC Transporters in Clinical Practice
Leonard, G. D., Fojo, T., & Bates, S. E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-411 · Cited by 817
The multidrug transporter, a double-edged sword.
Gottesman, M. M., & Pastan, I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37730-5 · Cited by 757
Self-citationModulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Self-citationNoonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7160 · Cited by 714
Multiple-Drug Resistance in Human Cancer
Flier, J. S., Underhill, L. H., Pastan, I., & Gottesman, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162207 · Cited by 692
Self-citationOvarian damage from chemotherapy and current approaches to its protection
Spears, N., Lopes, F., Stefansdottir, A., Rossi, V, De Felici, M., Anderson, R. A., & Klinger, F. G. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz027 · Cited by 657
Clinical Pharmacokinetics of Atorvastatin
Lennern??s, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00005 · Cited by 623
Phosphatidylcholine translocase: A physiological role for the mdr2 gene
Ruetz, S. (1994) · Cell · doi:10.1016/0092-8674(94)90446-4 · Cited by 599
ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
Eckford, P. D. W., & Sharom, F. J. (2009) · Chemical Reviews · doi:10.1021/cr9000226 · Cited by 597
Chan, L. M. S., Lowes, S., & Hirst, B. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.07.003 · Cited by 582
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
Self-citationDalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G., Taylor, C. W., Miller, T. P., & Salmon, S. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.415 · Cited by 556
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Tabatabaei Mirakabad, F. S., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 542
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Lee, G., Dallas, S., Hong, M., & Bendayan, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01513-8 · Cited by 539
Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29643-9 · Cited by 533
The Gut as a Barrier to Drug Absorption: Combined Role of Cytochrome P450 3A and P-Glycoprotein
Zhang, Y., & Benet, L. Z. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140030-00002 · Cited by 518
Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., & Willingham, M. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4486 · Cited by 484
Self-citationGENETIC ANALYSIS OF THE MULTIDRUG TRANSPORTER
Gottesman, M. M., Hrycyna, C. A., Schoenlein, P. V., Germann, U. A., & Pastan, I. (1995) · Annual Review of Genetics · doi:10.1146/annurev.ge.29.120195.003135 · Cited by 478
Self-citationATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
Horio, M., Gottesman, M. M., & Pastan, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3580 · Cited by 476
Self-citationCroop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., & Housman, D. E. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1346 · Cited by 463
Cellular and molecular aspects of drug transport in the kidney
Inui, K.-I., Masuda, S., & Saito, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00251.x · Cited by 450
Bourguignon, L. Y. W., Peyrollier, K., Xia, W., & Gilad, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800109200 · Cited by 442
Wacher, V. J., Silverman, J. A., Zhang, Y., & Benet, L. Z. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980082d · Cited by 423
Role of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Mayer, A., Takimoto, M., Fritz, E., Schellander, G., Kofler, K., & Ludwig, H. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2454::aid-cncr2820710805>3.0.co;2-2 · Cited by 412
An overview of cancer multidrug resistance: a still unsolved problem
Lage, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8111-5 · Cited by 408
P-glycoprotein—A mediator of multidrug resistance in tumour cells
Germann, U. A. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00057-3 · Cited by 405
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment: Miniperspective
Waghray, D., & Zhang, Q. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01457 · Cited by 400
Expression of P-Glycoprotein in High-Grade Osteosarcomas in Relation to Clinical Outcome
Baldini, N., Scotlandi, K., Barbanti-Bròdano, G., Manara, M. C., Maurici, D., Bacci, G., Bertoni, F., Picci, P., Sottili, S., Campanacci, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332103 · Cited by 399
Marie, J., Zittoun, R., & Sikic, B. (1991) · Blood · doi:10.1182/blood.v78.3.586.586 · Cited by 394
Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40219-6 · Cited by 393
Self-citationMultixenobiotic resistance as a cellular defense mechanism in aquatic organisms
Bard, S. (2000) · Aquatic Toxicology · doi:10.1016/s0166-445x(00)00088-6 · Cited by 392
Miller, D. S., Bauer, B., & Hartz, A. M. S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07109 · Cited by 392
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.
Raviv, Y., Pollard, H. B., Bruggemann, E. P., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39690-5 · Cited by 387
Self-citationTaxanes in cancer treatment: Activity, chemoresistance and its overcoming
Mosca, L., Ilari, A., Fazi, F., Assaraf, Y. G., & Colotti, G. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100742 · Cited by 385
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
Tchounwou, P. B., Dasari, S., Noubissi, F. K., Ray, P., & Kumar, S. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s267383 · Cited by 384
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.
Georges, E., Bradley, G., Gariepy, J., & Ling, V (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.152 · Cited by 384
Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Hu, T., Li, Z., Gao, C.-Y., & Cho, C. H. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6876 · Cited by 381
β‐Amyloid efflux mediated by p‐glycoprotein
Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J., Sharom, F. J., & Reiner, P. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00113.x · Cited by 380
Chaudhary, P., Mechetner, E., & Roninson, I. (1992) · Blood · doi:10.1182/blood.v80.11.2735.2735 · Cited by 379
Pascussi, J.-M., Drocourt, L., Fabre, J.-M., Maurel, P., & Vilarem, M.-J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12072-x · Cited by 372
Englund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A., & Artursson, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.010 · Cited by 368
Vaidyanathan, A., Sawers, L., Gannon, A.-L., Chakravarty, P., Scott, A. L., Bray, S. E., Ferguson, M. J., & Smith, G. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.203 · Cited by 364
Expression and function of efflux drug transporters in the intestine
Takano, M., Yumoto, R., & Murakami, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.005 · Cited by 356
Is the Role of the Small Intestine in First-Pass Metabolism Overemphasized?
Lin, J. H., Chiba, M., & Baillie, T. A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01402-9 · Cited by 352
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
Fox, E., & Bates, S. E. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.447 · Cited by 350
Functional involvement of P-glycoprotein in blood-brain barrier.
Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., & Tsuruo, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88713-6 · Cited by 347
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Cytochrome P450-mediated metabolism in the human gut wall
Thelen, K., & Dressman, J. B. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.05.0002 · Cited by 338
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
Fung, K. L., & Gottesman, M. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.014 · Cited by 335
Self-citationThe clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
Rowinsky, E. K., & Donehower, R. C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90086-2 · Cited by 321
Interactions among Drugs for HIV and Opportunistic Infections
Piscitelli, S. C., & Gallicano, K. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441307 · Cited by 320
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
Abdallah, H. M., Al-Abd, A. M., El-Dine, R. S., & El-Halawany, A. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2014.11.008 · Cited by 319
Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction
Thummel, K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00039-2 · Cited by 318
Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current Progress
Dong, X., & Mumper, R. J. (2010) · Nanomedicine · doi:10.2217/nnm.10.35 · Cited by 317
Paulsen, I. T., Skurray, R. A., Tam, R., Saier, M. H., Turner, R. J., Weiner, J. H., Goldberg, E. B., & Grinius, L. L. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02462.x · Cited by 317
Yabuuchi, H., Tamai, I., Nezu, J.-I., Sakamoto, K., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38199-6 · Cited by 316
Bourguignon, L. Y. W., Spevak, C. C., Wong, G., Xia, W., & Gilad, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027466 · Cited by 316
Drug–drug interaction mediated by inhibition and induction of P-glycoprotein
Lin, J. H. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00171-0 · Cited by 309
Wolking, S., Schaeffeler, E., Lerche, H., Schwab, M., & Nies, A. T. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0267-1 · Cited by 309
Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols
Jodoin, J., Demeule, M., & Béliveau, R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00175-6 · Cited by 300
Leschziner, G. D., Andrew, T., Pirmohamed, M., & Johnson, M. R. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500413 · Cited by 300
Molecular aspects of hepatobiliary transport
Muller, M., & Jansen, P. L. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.6.g1285 · Cited by 299
Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance
Kramer, R. A., Zakher, J., & Kim, G. (1988) · Science · doi:10.1126/science.3399900 · Cited by 295
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 294
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
Benet, L. Z., Izumi, T., Zhang, Y., Silverman, J. A., & Wacher, V. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00034-6 · Cited by 292
Farrell, R. J., Murphy, A., Long, A., Donnelly, S., Cherikuri, A., O'Toole, D., Mahmud, N., Keeling, P. W. N., Weir, D. G., & Kelleher, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70210-1 · Cited by 291
Hunter, J., & Hirst, B. H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00497-3 · Cited by 291
Structure and expression of the human MDR (P-glycoprotein) gene family.
Chin, J. E., Soffir, R., Noonan, K. E., Choi, K., & Roninson, I. B. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3808 · Cited by 288
The Multixenobiotic Resistance Mechanism in Aquatic Organisms
Kurelec, B. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145320 · Cited by 287
Ueda, K., Pastan, I., & Gottesman, M. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45397-5 · Cited by 286
Self-citationMarchetti, S., Mazzanti, R., Beijnen, J. H., & Schellens, J. H. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-927 · Cited by 284
Van der Bliek, A. M., Baas, F., Ten Houte de Lange, T., Kooiman, P. M., Van der Velde-Koerts, T., & Borst, P. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02653.x · Cited by 281
Potential Role of Drug Transporters in the Pathogenesis of Medically Intractable Epilepsy
Kwan, P., & Brodie, M. J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.31904.x · Cited by 281
Anglicheau, D., Verstuyft, C. A. A., Laurent-Puig, P., Becquemont, L., Schlageter, M.-H. A. A. G. A., Cassinat, B., Beaune, P., Legendre, C., & Thervet, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000073901.94759.36 · Cited by 281
P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine
Mouly, S., & Paine, M. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1026183200740 · Cited by 276
The multidrug resistance gene PDR1 from Saccharomyces cerevisiae.
Balzi, E., Chen, W., Ulaszewski, S., Capieaux, E., & Goffeau, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45464-6 · Cited by 276
Expression of the Multidrug-Resistant Gene in Hepatocarcinogenesis and Regenerating Rat Liver
Thorgeirsson, S. S., Huber, B. E., Sorrell, S., Fojo, A., Pastan, I., & Gottesman, M. M. (1987) · Science · doi:10.1126/science.3576227 · Cited by 273
Self-citationArceci, R. J., Croop, J. M., Horwitz, S. B., & Housman, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4350 · Cited by 265
From Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs)
Mantaj, J., Jackson, P. J. M., Rahman, K. M., & Thurston, D. E. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201510610 · Cited by 262
ATP binding cassette transporters and drug resistance in breast cancer.
Leonessa, F., & Clarke, R. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100043 · Cited by 259
Wu, C., Calcagno, A. M., & Ambudkar, S. V. (2008) · Current Molecular Pharmacology · doi:10.2174/1874-470210801020093 · Cited by 259
P-glycoprotein in human sarcoma: evidence for multidrug resistance.
Gerlach, J. H., Bell, D. R., Karakousis, C., Slocum, H. K., Kartner, N., Rustum, Y. M., Ling, V, & Baker, R. M. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.9.1452 · Cited by 255
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
Holland, M. L., Panetta, J. A., Hoskins, J. M., Bebawy, M., Roufogalis, B. D., Allen, J. D., & Arnold, J. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.033 · Cited by 157
Genovese, I., Ilari, A., Assaraf, Y. G., Fazi, F., & Colotti, G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.003 · Cited by 156
P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers
Maeng, H.-J., Yoo, H.-J., Kim, I.-W., Song, I.-S., Chung, S.-J., & Shim, C.-K. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10268 · Cited by 128
Jain, A. K., Swarnakar, N. K., Das, M., Godugu, C., Singh, R. P., Rao, P. R., & Jain, S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200011f · Cited by 89
Metadata
- Authors
- Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-01
- Volume
- 84
- Issue
- 1
- Pages
- 265-269
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2037621239
- Cited by
- 1,544
- References
- 21
- FWCI
- 32.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.